University at Buffalo spinoff Cytocybernetics is developing technology to screen new pharmaceuticals for cardiac safety.
Heart Safe Medicine
Hear from Glenna Bett, PhD, founder and CEO of CytoCybernetics on how their technology helps save the pharmaceutical industry time and money on drug development.
Study findings will help determine the best ways to teach a infant, based on their response to music.
Research Notes
Are You a Big Data or Health Sciences Researcher Working with Industry?
You could be eligible for a cost-sharing grant through the University at Buffalo. Apply for a UB CAT grant by March 15, 2018. Watch the webinar today for more information.
Keeping Your Research on Track:
SPS would like to remind you of changes that started last month:
Spring 2018 Workshops
The Office of Research Advancement invites you to participate in their research fundamentals workshops. Access the full programming schedule here.
UB Research at Work
UB helps companies to grow through licensed technologies, including:
UB startup ProOsseus executed a license to develop a novel nanoparticle for promoting bone regeneration.
UB startup POP Biotechnologies executed a license to a liposomal nanoparticle platform for therapeutic applications.
UB startup Neurovascular Diagnostics executed a license and received an SBIR award to develop a test for detecting unruptured brain aneurysms.
UB licensee Expansion Therapeutics closed a $55.3 million investment round. Congratulations!
Knowledge is Power
Research by Yunju Nam, PhDin the school of social work, suggests that greater knowledge of a savings program for Oklahoma youth would increase participation from minorities. The full article may be read here.